WallStreetZenWallStreetZen

NASDAQ: INO
Inovio Pharmaceuticals Inc Stock Ownership - Who owns Inovio Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Inovio Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jacqueline Elizabeth SheaChief Executive Officer2025-02-269,088$1.98
$17.99kSell
Laurent HumeauChief Scientific Officer2025-02-261,584$1.98
$3.14kSell
Laurent HumeauChief Scientific Officer2025-02-262,059$1.98
$4.08kSell
Peter KiesCFO2025-02-262,362$1.98
$4.68kSell
Peter KiesCFO2025-02-262,960$1.98
$5.86kSell
Jacqueline Elizabeth SheaChief Executive Officer2025-02-262,493$1.98
$4.94kSell
Peter KiesCFO2024-05-152,562$13.07
$33.49kSell
Jacqueline Elizabeth SheaChief Executive Officer2024-05-157,718$13.07
$100.87kSell
Laurent HumeauChief Scientific Officer2024-05-151,703$13.07
$22.26kSell
Jacqueline Elizabeth SheaChief Executive Officer2024-05-102,392$10.65
$25.47kSell

1 of 1

INO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INO insiders and whales buy or sell their stock.

INO Shareholders

What type of owners hold Inovio Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Austin W. Greenhouse David M. Marxe56.32%20,650,987$39.44MInsider
Tee Khiang Ng13.36%4,899,931$9.36MInsider
Deep Track Capital LP8.51%3,119,162$5.96MInstitution
Jong Joseph Kim6.40%2,346,000$4.48MInsider
Blackrock Inc5.20%1,908,511$3.65MInstitution
Vanguard Group Inc4.56%1,673,588$3.20MInstitution
Stonepine Capital Management LLC2.86%1,050,000$2.01MInstitution
Beng Lee Gan2.24%823,045$1.57MInsider
Kevin Rassas1.98%726,088$1.39MInsider
Aigh Capital Management LLC1.78%654,115$1.25MInstitution

1 of 3

INO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INO30.11%69.89%Net SellingNet Selling
GNTA1.97%0.00%
ADAP6.37%93.63%Net Selling
ADAG17.73%0.00%
MIST46.02%24.06%
View Top Biotech Stocks

Inovio Pharmaceuticals Stock Ownership FAQ

Who owns Inovio Pharmaceuticals?

Inovio Pharmaceuticals (NASDAQ: INO) is owned by 36.45% institutional shareholders, 84.59% Inovio Pharmaceuticals insiders, and 0.00% retail investors. Austin W. Greenhouse David M. Marxe is the largest individual Inovio Pharmaceuticals shareholder, owning 20.65M shares representing 56.32% of the company. Austin W. Greenhouse David M. Marxe's Inovio Pharmaceuticals shares are currently valued at $40.06M.

If you're new to stock investing, here's how to buy Inovio Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.